ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Takeda Pharmaceutical Co

Takeda Pharmaceutical Co (0A87)

0,00
0,00
(0,00%)
Fermé 16 Juin 5:30PM

Takeda Pharmaceutical Co (0A87) Action

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
-
( - )
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Cap du marché
Clôture Veille
0,00
Ouverture
-
Dernière Transaction
(O)
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
US$ 4 431 130
Actions en circulation
1 579 837 574
Rendement du Dividende (LTM)
200 (4,02%)
Ratio Cours sur Bénéfices
42,48
Bénéfice par action (BPA)
119,64
Chiffre d'affairess (LTM)
4,51T
Bénéfice net (LTM)
191,76B

À propos de Takeda Pharmaceutical Co

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, immunology, onco... Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, immunology, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Alofisel, Dexilant, Pantoloc/Controloc, Adynovate/Adynovi, Feiba Fiber, Recombinate, Hemofil, Immunate, Immunine, Takhzyro, Livtencity, ADZYNMA, Elaprase, Replagal, Advate, Flexbumin, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Exkivity, FRUZAQLA, Ninlaro, Velcade, Azilva, Iclusig, Leuplin/Enantone, Adcetris, vyvanse/elvanse, Trintellix, QDENGA, and Alunbrig brands. It has in-licensing agreements with BioMarin, Luxna Biotech, GlaxoSmithKline, Halozyme, and Kamada; collaborations with Neurocrine Biosciences, Inc., Seagen Inc., Anima Biotech, Denali Therapeutics, KSQ Therapeutics, Noile-Immune Biotech, Center for iPS Cell Research Institute, Kyoto University (CiRA), and Charles River Laboratories; licensing agreement with Mirum Pharmaceuticals, UCSD/Fortis Advisors, PeptiDream, MD Anderson Cancer Center, and Teva Pharmaceutical Industries; collaboration and licensing agreement with Arrowhead Pharmaceuticals Inc., Engitix, Genevant Sciences Corporation, Sosei, Zedira/Dr. Falk Pharma, Exelixi GlaxoSmithKline, Heidelberg Pharma, HUTCHMED, KM Biologics, and Ovid Therapeutics Inc.; and collaboration with ZEDIRA GmbH and Dr. Falk Pharma GmbH. It has research collaboration and licensing agreement with Crescendo Biologics. The company was founded in 1781 and is headquartered in Tokyo, Japan. Show more

Secteur
-
Industrie
-
Site Web
Siège social
Tokyo, Japan
Fondé
1781
Takeda Pharmaceutical Co est coté dans le secteur de la London Stock Exchange avec le ticker 0A87. Le dernier cours de clôture d'Takeda Pharmaceutical était de US$0,00. Au cours de la dernière année, les actions de Takeda Pharmaceutical ont été négociées dans une fourchette de prix de US$ 0,00 à US$ 0,00.

Takeda Pharmaceutical compte actuellement 1 579 837 574 actions en circulation. Takeda Pharmaceutical a un ratio cours/bénéfice (ratio PE) de 42.48.

0A87 Dernières nouvelles

Aucune actualité à afficher pour le moment.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

0A87 - Frequently Asked Questions (FAQ)

What is the current Takeda Pharmaceutical Co share price?
The current share price of Takeda Pharmaceutical Co is US$ 0,00
How many Takeda Pharmaceutical Co shares are in issue?
Takeda Pharmaceutical Co has 1 579 837 574 shares in issue
What is the 1 year trading range for Takeda Pharmaceutical Co share price?
Takeda Pharmaceutical Co has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the PE ratio of Takeda Pharmaceutical Co?
The price to earnings ratio of Takeda Pharmaceutical Co is 42,48
What is the cash to sales ratio of Takeda Pharmaceutical Co?
The cash to sales ratio of Takeda Pharmaceutical Co is 1,78
What is the registered address of Takeda Pharmaceutical Co?
The registered address for Takeda Pharmaceutical Co is 1-1, Nihonbashi-Honcho 2-chome, Tokyo, Tokyo, 103-8668
What is the Takeda Pharmaceutical Co website address?
The website address for Takeda Pharmaceutical Co is www.takeda.com

0A87 Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock